October 5, 2024

Therapeutic Respiratory Devices Market Size Analysis 2023 To 2032

The global therapeutic respiratory devices market size accounted for US$ 20.49 Bn in 2022 and is projected to reach around USD 40.01 Bn by 2032, growing at a CAGR of 6.92% from 2023 to 2032.

Therapeutic Respiratory Devices Market Size 2023 To 2032

Key Takeaways:

  • North America generated more than 32% of the revenue share in 2022.
  • By Type, the ventilators segment is predicted to dominate the global market from 2023 to 2032.
  • By End-user, the hospitals segment is expected to lead the global market from 2023 to 2032.

Report Summary

The global therapeutic respiratory devices market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the therapeutic respiratory devices market across the globe.

A comprehensive estimate on the therapeutic respiratory devices market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of therapeutic respiratory devices during the forecast period. Price point comparison by region with global average price is also considered in the study.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3106

Therapeutic Respiratory Devices Market Report Scope

Report CoverageDetails
Market Size in 2023USD 21.91 Billion
Market Size by 2032USD 40.01 Billion
Growth Rate from 2023 to 2032CAGR of 6.92%
Largest MarketNorth America
Base Year2022
Forecast Period2023 to 2032
Segments CoveredBy Types and By End-User
Regions CoveredNorth America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized therapeutic respiratory devices market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read: Generative AI in Pharmaceutical Market Size Analysis 2023 To 2032

Therapeutic Respiratory Devices Market Players

The report includes the profiles of key therapeutic respiratory devices market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Major companies operating in this area

  • GE Healthcare
  • Koninklijke Philips N.V.
  • ICU Medical (Smiths Medical)
  • Invacare Corporation
  • Medtronic
  • Fisher & Paykel Healthcare
  • ResMed
  • Linde
  • Mindray
  • Chart Industries
  • Drägerwerk AG & Co. KGaA
  • DeVilbiss Healthcare

Market Segmentation

By Types

  • Ventilators
  • Nebulizers
  • Oxygen Therapy Devices
  • Positive Airway Pressure Devices

By End-User

  • Hospitals
  • Home Healthcare
  • Emergency Centers

Regional Segmentation

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
  • In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Therapeutic Respiratory Devices Market 

5.1. COVID-19 Landscape: Therapeutic Respiratory Devices Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Therapeutic Respiratory Devices Market, By Types

8.1. Therapeutic Respiratory Devices Market Revenue and Volume, by Types, 2023-2032

8.1.1. Ventilators

8.1.1.1. Market Revenue and Volume Forecast (2020-2032)

8.1.2. Nebulizers

8.1.2.1. Market Revenue and Volume Forecast (2020-2032)

8.1.3. Oxygen Therapy Devices

8.1.3.1. Market Revenue and Volume Forecast (2020-2032)

8.1.4. Positive Airway Pressure Devices

8.1.4.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 9. Global Therapeutic Respiratory Devices Market, By End-User

9.1. Therapeutic Respiratory Devices Market Revenue and Volume, by End-User, 2023-2032

9.1.1. Hospitals

9.1.1.1. Market Revenue and Volume Forecast (2020-2032)

9.1.2. Home Healthcare

9.1.2.1. Market Revenue and Volume Forecast (2020-2032)

9.1.3. Emergency Centers

9.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 10. Global Therapeutic Respiratory Devices Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Volume Forecast, by Types (2020-2032)

10.1.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.1.3. U.S.

10.1.3.1. Market Revenue and Volume Forecast, by Types (2020-2032)

10.1.3.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Volume Forecast, by Types (2020-2032)

10.1.4.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.2. Europe

10.2.1. Market Revenue and Volume Forecast, by Types (2020-2032)

10.2.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.2.3. UK

10.2.3.1. Market Revenue and Volume Forecast, by Types (2020-2032)

10.2.3.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.2.4. Germany

10.2.4.1. Market Revenue and Volume Forecast, by Types (2020-2032)

10.2.4.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.2.5. France

10.2.5.1. Market Revenue and Volume Forecast, by Types (2020-2032)

10.2.5.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Volume Forecast, by Types (2020-2032)

10.2.6.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.3. APAC

10.3.1. Market Revenue and Volume Forecast, by Types (2020-2032)

10.3.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.3.3. India

10.3.3.1. Market Revenue and Volume Forecast, by Types (2020-2032)

10.3.3.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.3.4. China

10.3.4.1. Market Revenue and Volume Forecast, by Types (2020-2032)

10.3.4.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.3.5. Japan

10.3.5.1. Market Revenue and Volume Forecast, by Types (2020-2032)

10.3.5.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Volume Forecast, by Types (2020-2032)

10.3.6.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.4. MEA

10.4.1. Market Revenue and Volume Forecast, by Types (2020-2032)

10.4.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.4.3. GCC

10.4.3.1. Market Revenue and Volume Forecast, by Types (2020-2032)

10.4.3.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.4.4. North Africa

10.4.4.1. Market Revenue and Volume Forecast, by Types (2020-2032)

10.4.4.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.4.5. South Africa

10.4.5.1. Market Revenue and Volume Forecast, by Types (2020-2032)

10.4.5.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Volume Forecast, by Types (2020-2032)

10.4.6.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.5. Latin America

10.5.1. Market Revenue and Volume Forecast, by Types (2020-2032)

10.5.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.5.3. Brazil

10.5.3.1. Market Revenue and Volume Forecast, by Types (2020-2032)

10.5.3.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Volume Forecast, by Types (2020-2032)

10.5.4.2. Market Revenue and Volume Forecast, by End-User (2020-2032)

Chapter 11. Company Profiles

11.1. GE Healthcare

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Koninklijke Philips N.V.

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. ICU Medical (Smiths Medical)

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Invacare Corporation

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Medtronic

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Fisher & Paykel Healthcare

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. ResMed

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Linde

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Mindray

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Chart Industries

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Emailsales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com